← All diseases
Cancer
Prostate cancer (metastatic)
Do you want to receive a message if there is new research about Prostate cancer (metastatic)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication you'll find one sentence explaining what was studied — and you'll be notified as soon as there is new research on Prostate cancer (metastatic). View what Premium costs.
Publications (1468)
- Relationship between oxidative balance score and prostate cancer: a cross-sectional study of NHANES, 1999-2010. (2024/09/16) ♡
- Testing home-based exercise strategies in underserved minority cancer patients undergoing chemotherapy (THRIVE) trial: a study protocol. (2024/09/16) ♡
- Association between low total serum testosterone and body mass index in Australian survivors of testicular cancer: a retrospective analysis. (2024/09/03) ♡
- Measuring the impact of new risk factors within survival models. (2024/09/03) ♡
- Reactivation of nucleases with peroxidation damages induced by a menadione: ascorbate combination devastates human prostate carcinomas: ultrastructural aspects. (2024/09/02) ♡
- Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. Markers of bone metabolism and overall survival in men with bone-metastatic hormone sensitive prostate cancer (HSPC): A subset analysis of SWOG S1216, a phase III trial of androgen deprivation with or without orteronel. (2024/09/01) ♡
- Does the type of the previous biopsy affect the fusion prostate biopsy results? (2024/09/01) ♡
- Sleep and health improvement programme (SHIP) for patients with prostate cancer and caregivers. (2024/08/31) ♡
- Quality of Life Determinants in Patients with Metastatic Prostate Cancer: Insights from a Cross-Sectional Questionnaire-Based Study. (2024/08/26) ♡
- How a population-based cohort of men estimate lifetime risk of prostate cancer in a survey before entering a prostate cancer screening trial in Sweden? (2024/08/17) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Is Minimal Change Disease Associated with Prostate Cancer or Is Age Just a Number? (2024/08/13) ♡
- Prognostic factors for non‑metastatic castration‑resistant prostate cancer treated with androgen receptor signaling inhibitors. (2024/08/08) ♡
- Association between Bisphenol A and Prostate-Specific Antigen (PSA) among U.S. Older Males: National Health and Nutrition Examination Survey (NHANES), 2003-2012. (2024/08/06) ♡
- Scientific opinion on the tolerable upper intake level for vitamin E. (2024/08/02) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Heterogeneity of Radiological Progression Patterns and Association with Outcomes in Patients with Metastatic Prostate Cancer. (2024/08/01) ♡
- Development and Validation of a Machine Learning Model for Bone Metastasis in Prostate Cancer: Based on Inflammatory and Nutritional Indicators. (2024/08/01) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial. (2024/08/01) ♡
- Cytotoxicity of Benzofuran-Containing Simplified Viniferin Analogues. (2024/08/01) ♡
- The role of endocrine gland derived vascular growth factor/ Prokineticin-1 in human prostate cells. (2024/07/31) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Primary Sternal Leiomyosarcoma. (2024/07/26) ♡
- Novel systems biology experimental pipeline reveals matairesinol's antimetastatic potential in prostate cancer: an integrated approach of network pharmacology, bioinformatics, and experimental validation. (2024/07/25) ♡
- A Compound That Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate Cancer. (2024/07/02) ♡
- Splice-switching antisense oligonucleotide controlling tumor suppressor REST is a novel therapeutic medicine for neuroendocrine cancer. (2024/07/02) ♡
- Healthy dietary patterns and risk of prostate cancer in men at high genetic risk. (2024/07/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Enhancing circulatory myokines and extracellular vesicle uptake with targeted exercise in patients with prostate cancer (the MYEX trial): a single-group crossover study. (2024/07/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Cancer-associated fibroblasts (CAFs) gene signatures predict outcomes in breast and prostate tumor patients. (2024/06/27) ♡
- Mediating Effects of Self-Efficacy and Illness Perceptions on Mental Health in Men with Localized Prostate Cancer: A Secondary Analysis of the Prostate Cancer Patient Empowerment Program (PC-PEP) Randomized Controlled Trial. (2024/06/27) ♡
- Estimating disease burden using national linked electronic health records: a study using an English population-based cohort. (2024/06/19) ♡
- Effect of smoking on prostate cancer: Results from the National Health and Nutrition Examination Survey 2003-2018 and Mendelian randomization analyses. (2024/06/04) ♡
- The Association of County-level Prostate-specific Antigen Screening with Metastatic Prostate Cancer and Prostate Cancer Mortality. (2024/06/01) ♡
- Development of Novel Models of Aggressive Variants of Castration-resistant Prostate Cancer. (2024/06/01) ♡
- Tumour-based Mutational Profiles Predict Visceral Metastasis Outcome and Early Death in Prostate Cancer Patients. (2024/06/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Nonsurgical Interventions to Prevent Disease Progression in Prostate Cancer Patients on Active Surveillance: A Systematic Review and Meta-analysis. (2024/06/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Metabolic Response to Androgen Deprivation Therapy of Prostate Cancer. (2024/05/24) ♡
- Cost analysis of next-generation imaging in high-risk prostate cancer staging. (2024/05/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Plant-Based Diets and Disease Progression in Men With Prostate Cancer. (2024/05/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Creatine supplementation and resistance training to preserve muscle mass and attenuate cancer progression (CREATINE-52): a protocol for a double-blind randomized controlled trial. (2024/04/18) ♡
- Excess weight, weight gain, and prostate cancer risk and prognosis: the PROCA-life study. (2024/04/09) ♡
- Tale of two zones: investigating the clinical outcomes and research gaps in peripheral and transition zone prostate cancer through a systematic review and meta-analysis. (2024/04/03) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. A systematic review of cytoreductive prostatectomy outcomes and complications in oligometastatic disease. (2024/04/01) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. GnRH antagonist monotherapy versus a GnRH agonist plus bicalutamide for advanced hormone-sensitive prostate cancer; KYUCOG-1401. (2024/04/01) ♡
- Oral Toxicities of PSMA-Targeted Immunotherapies for The Management of Prostate Cancer. (2024/04/01) ♡
- Treatment Patterns of Bone-targeting Agents Among Solid Tumor Patients With Bone Metastases: An Analysis of Electronic Health Record Data in the United States From 2014 to 2018. (2024/04/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. PARP Inhibitors in Metastatic Prostate Cancer: A Comprehensive Systematic Review and Meta-analysis of Existing Evidence. (2024/04/01) ♡
- The Effect of Treatment Intensification on Other-Cause Mortality in Clear-Cell Metastatic Renal Cell Carcinoma Patients. (2024/04/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with non-metastatic and metastatic prostate cancer: A meta-analysis and systematic review. (2024/04/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Understanding the incidence, duration, and severity of symptoms through daily symptom monitoring among frail and non-frail older patients receiving metastatic prostate cancer treatments. (2024/04/01) ♡
- A phase IIb randomized placebo-controlled trial testing the effect of MAG-EPA long-chain omega-3 fatty acid dietary supplement on prostate cancer proliferation. (2024/03/22) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Chimeric Antigen Receptor-Modified T Cell Therapy in Metastatic Castrate-Resistant Prostate Cancer: Promise and Potential. (2024/03/05) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Lipid metabolism, amino acid metabolism, and prostate cancer: a crucial metabolic journey. (2024/03/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.